RE:RE:RE:RE:RE:RE:RE:JPM
With all due respect, I don’t believe the biotech selloff as anything to do with Thera. Thera as 2 good products to sell, but have demonstrated a poor delivery capability at all levels, be it sales, communication or marketing which translated into low results and expectations.
It’s all fine to talk of a potential rosy future (The new NASH pudding flavour) but once this future becomes the present (like the Trogarzo pudding flavour) it must be followed by concrete results.
Tons of reasons might be given for failure to achieve results but now the investors are saying that proof is in the pudding and the Trogarzo pudding doesn’t taste that great yet and they’re not willing to buy into the new NASH flavour for now.
Will Thera change to meet the challenge or will they be bought out by a company with a better tool box.